LAVINIA P MIDDLETON to Follow-Up Studies
This is a "connection" page, showing publications LAVINIA P MIDDLETON has written about Follow-Up Studies.
Connection Strength
0.163
-
Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med. 2014 Jun; 3(3):492-9.
Score: 0.042
-
Expression of ERalpha and ERbeta in lobular carcinoma in situ. Histopathology. 2007 Jun; 50(7):875-80.
Score: 0.026
-
E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. Ann Diagn Pathol. 2002 06; 6(3):141-7.
Score: 0.018
-
Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002 Apr 01; 94(7):1910-6.
Score: 0.018
-
Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000 Dec; 24(12):1650-6.
Score: 0.017
-
The histological spectrum of hemangiopericytoma: application of immunohistochemical analysis including proliferative markers to facilitate diagnosis and predict prognosis. Hum Pathol. 1998 Jun; 29(6):636-40.
Score: 0.014
-
Imaging of Intracystic Papillary Carcinoma. Curr Probl Diagn Radiol. 2019 Jul - Aug; 48(4):348-352.
Score: 0.014
-
A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ. Cancer Prev Res (Phila). 2018 05; 11(5):295-302.
Score: 0.014